CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Metsera backers establish new biotech armed with China-licensed immunology asset

PartnershipPositive
AI Analysis

Summary

Sentivera, a newly established biotech backed by PHP and ARCH, has secured a China-licensed immunology asset through a licensing deal with Haisco.

Importance:3/10
Sentiment:
0.30
company formationlicensing dealimmunologyChinapartnership
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 26, 2026 10:40 AM

Read Original